Edward C. Wood

The Company's principal activity is to develop, manufacture, market and distribute a hemoglobin-based blood substitute product. The Company's product, PolyHeme(R) blood substitute, provides an alternative to transfused blood for use in the treatment of acute blood loss. The company uses a proprietary process of separation, filtration, chemical modification purification and formulation to produce PolyHeme. PolyHeme is designed to avoid potential undesirable effects such as vasoconstriction, kidney dysfunction, liver dysfunction and gastrointestinal distress. Clinical trials of PolyHeme have been conducted at multiple locations in the United States. The company has entered into license agreements with Pfizer Inc and Hemocare Ltd an Israeli corporation to develop manufacture and distribute PolyHeme in certain European, Middle Eastern and African countries. The Company is in development stage.

Part of Terumo Corp., Mission Medical, Inc. develops blood collection and separation products. The company is based in Fremont, CA. Mission Medical was acquired by Terumo Medical Corp. from OXBOW Equities Corp. on February 25, 2005 for $18 million.

MonoGen, Inc. is a medical device and diagnostics company. It provides cytological screening and diagnostic products to healthcare providers in the anatomic pathology industry. The company was founded on July 28, 1995 and is headquartered in Lincolnshire, IL.

Engineering & Research Associates, Inc. manufactures surgical and medical instruments. The company was founded in 1974 and is headquartered in Tucson, AZ.

ArcScan, Inc. develops and markets ultrasound scanners for ophthalmology. It provides the software tools to clean up scanned existing paper, maps or photos, and selectively vectorize all or parts of the raster. The company was founded by John D. Watson in February 2007 and is headquartered in Golden, CO.